Related Experiment Videos
Cardiac disease in myotonic dystrophy
1Institute of Medical Genetics, University of Wales College of Medicine, Cardiff, UK.
Insights
Myotonic dystrophy frequently causes cardiac issues like arrhythmias and conduction blocks. Early cardiac monitoring and careful anesthetic management are crucial for patients with this genetic muscle disorder.
Area of Science:
- Cardiology
- Genetics
- Neuromuscular Disorders
Background:
- Cardiac disease is a significant complication of myotonic dystrophy.
- Advances in molecular and cardiological techniques enhance understanding of its cardiac manifestations.
- Conduction disturbances and tachyarrhythmias are common in myotonic dystrophy patients.
Purpose of the Study:
- To review the cardiac complications associated with myotonic dystrophy.
- To discuss the molecular basis and histopathological findings of myotonic dystrophy heart disease.
- To provide recommendations for clinical management and diagnosis.
Main Methods:
- Review of recent molecular techniques and cardiological investigations.
- Analysis of histopathological findings including fibrosis and myocyte hypertrophy.
- Examination of potential roles for myotonin protein kinase and other genetic factors.
Main Results:
- Cardiac complications, including conduction disturbances and arrhythmias, correlate with disease severity in some cases.
- Sudden death can occur early due to ventricular arrhythmias or heart block.
- Histopathology reveals fibrosis, myocyte hypertrophy, and fatty infiltration, particularly in the cardiac conduction system.
Conclusions:
- Myotonic dystrophy requires vigilant cardiac surveillance, including regular ECGs and Holter monitoring.
- Anesthetic management needs careful consideration due to high cardiorespiratory complication risks.
- Consider myotonic dystrophy in undiagnosed patients presenting with cardiac arrhythmias or conduction blocks.
Abstract:
Cardiac disease is a well-known complication of myotonic dystrophy, understanding of which has been increased by recent advances in both molecular techniques and cardiological investigations. Conduction disturbances and tachyarrhythmias occur commonly in myotonic dystrophy. These have been shown to have a broad correlation in severity with both neuromuscular disease and the extent of the molecular defect in some, but not all, studies. Clinical evidence of generalised cardiomyopathy is unusual. The rate of progression differs widely between individuals; sudden death may be caused by ventricular arrhythmias or complete heart block, and this can be at an early stage of disease. A familial tendency towards cardiac complications has been shown in some studies. The histopathology is of fibrosis, primarily in the conducting system and sino-atrial node, myocyte hypertrophy and fatty infiltration. Electron microscopy shows prominent I-bands and myofibrillar degeneration. Myotonin protein kinase, the primary product of the myotonic dystrophy gene, may be located at the intercalated discs and have a different isoform in cardiac tissue. The role of other genes or the normal myotonic dystrophy allele in myotonic heart disease has yet to be determined. Suggestions for clinical management include a careful cardiac history and a 12-lead ECG at least every year, with a low threshold for use of 24 h Holter monitoring. Extra care should be taken before, during and after general anaesthetics, which carry a high frequency of cardiorespiratory complications. Finally, myotonic dystrophy should be considered in previously undiagnosed patients presenting to a cardiologist or general physician with suspected arrhythmia or conduction block.